Project Details
Description
A Randomized Phase 2 Trial of PF-00299804 vs. Erlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/08 → 12/31/12 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.